Execution of Pharma Tariffs Brings These ETFs Into Focus
President Donald Trump’s 100% tariff on certain patented pharmaceutical products took effect for covered drugmakers on Sept. 29, raising questions about the potential impacts on drug prices, domestic manufacturing and smaller pharmaceutical companies.The tariff was imposed under Section 232 and app…
President Donald Trump’s 100% tariff on certain patented pharmaceutical products took effect for covered drugmakers on Sept. 29, raising questions about the potential impacts on drug prices, domestic manufacturing and smaller pharmaceutical companies.The tariff was imposed under Section 232 and app…
What's Your Reaction?
